
Feb 25 (Reuters) - Plus Therapeutics Inc PSTV.O:
PLUS THERAPEUTICS ANNOUNCES NEW CATEGORY III CPT CODE FOR CONVECTION-ENHANCED DELIVERY USED WITH REYOBIQ™
PLUS THERAPEUTICS INC: ARE ON TRACK TO COMPLETE ENROLLMENT IN PHASE 2 RECURRENT GLIOBLASTOMA TRIAL IN 2026
PLUS THERAPEUTICS INC - NEW CPT CODE EFFECTIVE JANUARY 1, 2027